{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:33:14Z","timestamp":1790087594833,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12883-015-0367-4","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T11:08:24Z","timestamp":1438168104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Early statin use in ischemic stroke patients treated with recanalization therapy: retrospective observational study"],"prefix":"10.1186","volume":"15","author":[{"given":"Jihoon","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oh Young","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Sung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juneyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon-Ku","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip B.","family":"Gorelick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Joon","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"issue":"Suppl 1","key":"367_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000200455","volume":"27","author":"CA Molina","year":"2009","unstructured":"Molina CA, Alvarez-Sabin J. Recanalization and reperfusion therapies for acute ischemic stroke. Cerebrovasc Dis. 2009;27 Suppl 1:162\u20137.","journal-title":"Cerebrovasc Dis"},{"issue":"9849","key":"367_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(12)61299-9","volume":"380","author":"RG Nogueira","year":"2012","unstructured":"Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012;380(9849):1231\u201340.","journal-title":"Lancet"},{"issue":"9849","key":"367_CR3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0140-6736(12)61384-1","volume":"380","author":"JL Saver","year":"2012","unstructured":"Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, et al. Solitaire flow restoration device versus the merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012;380(9849):1241\u20139.","journal-title":"Lancet"},{"issue":"10","key":"367_CR4","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1097\/00004647-199710000-00006","volume":"17","author":"J Aronowski","year":"1997","unstructured":"Aronowski J, Strong R, Grotta JC. Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab. 1997;17(10):1048\u201356.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"367_CR5","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1161\/01.STR.0000170711.43405.81","volume":"36","author":"M Rubiera","year":"2005","unstructured":"Rubiera M, Alvarez-Sabin J, Ribo M, Montaner J, Santamarina E, Arenillas JF, et al. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke. 2005;36(7):1452\u20136.","journal-title":"Stroke"},{"issue":"12","key":"367_CR6","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1161\/STROKEAHA.107.508853","volume":"39","author":"HP Adams Jr","year":"2008","unstructured":"Adams Jr HP, Leira EC, Torner JC, Barnathan E, Padgett L, Effron MB, et al. Treating patients with \u2018wake-up\u2019 stroke: the experience of the AbESTT-II trial. Stroke. 2008;39(12):3277\u201382.","journal-title":"Stroke"},{"issue":"9","key":"367_CR7","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1161\/STROKEAHA.110.599662","volume":"42","author":"M Siebler","year":"2011","unstructured":"Siebler M, Hennerici MG, Schneider D, von Reutern GM, Seitz RJ, Rother J, et al. Safety of Tirofiban in acute ischemic stroke: the SaTIS trial. Stroke. 2011;42(9):2388\u201392.","journal-title":"Stroke"},{"issue":"9843","key":"367_CR8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0140-6736(12)60949-0","volume":"380","author":"SM Zinkstok","year":"2012","unstructured":"Zinkstok SM, Roos YB. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial. The Lancet. 2012;380(9843):731\u20137.","journal-title":"The Lancet"},{"issue":"1-2","key":"367_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jns.2011.05.026","volume":"308","author":"M Cappellari","year":"2011","unstructured":"Cappellari M, Deluca C, Tinazzi M, Tomelleri G, Carletti M, Fiaschi A, et al. Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study. J Neurol Sci. 2011;308(1-2):128\u201334.","journal-title":"J Neurol Sci"},{"issue":"22","key":"367_CR10","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1161\/CIRCULATIONAHA.104.516757","volume":"112","author":"L Zhang","year":"2005","unstructured":"Zhang L, Zhang ZG, Ding GL, Jiang Q, Liu X, Meng H, et al. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat. Circulation. 2005;112(22):3486\u201394.","journal-title":"Circulation"},{"issue":"9","key":"367_CR11","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1073\/pnas.91.9.3670","volume":"91","author":"BA Keyt","year":"1994","unstructured":"Keyt BA, Paoni NF, Refino CJ, Berleau L, Nguyen H, Chow A, et al. A faster-acting and more potent form of tissue plasminogen activator. Proc Natl Acad Sci U S A. 1994;91(9):3670\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"367_CR12","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1161\/01.STR.31.10.2442","volume":"31","author":"U Laufs","year":"2000","unstructured":"Laufs U, Gertz K, Huang P, Nickenig G, Bohm M, Dirnagl U, et al. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke. 2000;31(10):2442\u20139.","journal-title":"Stroke"},{"issue":"1","key":"367_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pneurobio.2009.02.002","volume":"88","author":"PJ van der Most","year":"2009","unstructured":"van der Most PJ, Dolga AM, Nijholt IM, Luiten PG, Eisel UL. Statins: mechanisms of neuroprotection. Prog Neurobiol. 2009;88(1):64\u201375.","journal-title":"Prog Neurobiol"},{"issue":"7","key":"367_CR14","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1161\/01.STR.0000226923.48905.39","volume":"37","author":"S Wang","year":"2006","unstructured":"Wang S, Lee SR, Guo SZ, Kim WJ, Montaner J, Wang X, et al. Reduction of tissue plasminogen activator-induced matrix metalloproteinase-9 by simvastatin in astrocytes. Stroke. 2006;37(7):1910\u20132.","journal-title":"Stroke"},{"issue":"7","key":"367_CR15","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1212\/WNL.0b013e318281cc83","volume":"80","author":"M Cappellari","year":"2013","unstructured":"Cappellari M, Bovi P, Moretto G, Zini A, Nencini P, Sessa M, et al. The THRombolysis and STatins (THRaST) study. Neurology. 2013;80(7):655\u201361.","journal-title":"Neurology"},{"issue":"6","key":"367_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1212\/WNL.0b013e318245d22c","volume":"78","author":"JH Park","year":"2012","unstructured":"Park JH, Ko Y, Kim WJ, Jang MS, Yang MH, Han MK, et al. Is asymptomatic hemorrhagic transformation really innocuous? Neurology. 2012;78(6):421\u20136.","journal-title":"Neurology"},{"issue":"2","key":"367_CR17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1161\/01.STR.0000152331.93770.18","volume":"36","author":"EA Noser","year":"2005","unstructured":"Noser EA, Shaltoni HM, Hall CE, Alexandrov AV, Garami Z, Cacayorin ED, et al. Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke. 2005;36(2):292\u20136.","journal-title":"Stroke"},{"issue":"1","key":"367_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams Jr HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. definitions for use in a multicenter clinical trial. TOAST. trial of org 10172 in acute stroke treatment. Stroke. 1993;24(1):35\u201341.","journal-title":"Stroke"},{"issue":"6","key":"367_CR19","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S0002-9149(03)00820-8","volume":"92","author":"CB Newman","year":"2003","unstructured":"Newman CB, Palmer G, Silbershatz H, Szarek M. Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients. Am J Cardiol. 2003;92(6):670\u20136.","journal-title":"Am J Cardiol"},{"issue":"1","key":"367_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","volume":"19","author":"M Schachter","year":"2005","unstructured":"Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol. 2005;19(1):117\u201325.","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"367_CR21","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/STROKEAHA.110.596734","volume":"42","author":"D Ni Chroinin","year":"2011","unstructured":"Ni Chroinin D, Callaly EL, Duggan J, Merwick A, Hannon N, Sheehan O, et al. Association between acute statin therapy, survival, and improved functional outcome after ischemic stroke: the North Dublin Population stroke study. Stroke. 2011;42(4):1021\u20139.","journal-title":"Stroke"},{"issue":"13","key":"367_CR22","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5\u00a0h after acute ischemic stroke. N Engl J Med. 2008;359(13):1317\u201329.","journal-title":"N Engl J Med"},{"issue":"24","key":"367_CR23","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"Group TNIoNDaSr-PSS","year":"1995","unstructured":"Group TNIoNDaSr-PSS. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581\u20137.","journal-title":"N Engl J Med"},{"issue":"9558","key":"367_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","volume":"369","author":"N Wahlgren","year":"2007","unstructured":"Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. Lancet. 2007;369(9558):275\u201382.","journal-title":"Lancet"},{"issue":"4","key":"367_CR25","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1161\/01.CIR.0000136588.62638.5E","volume":"110","author":"S Kinlay","year":"2004","unstructured":"Kinlay S, Schwartz GG, Olsson AG, Rifai N, Sasiela WJ, Szarek M, et al. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Circulation. 2004;110(4):386\u201391.","journal-title":"Circulation"},{"issue":"11","key":"367_CR26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-140-11-200406010-00006","volume":"140","author":"FA Spencer","year":"2004","unstructured":"Spencer FA, Allegrone J, Goldberg RJ, Gore JM, Fox KA, Granger CB, et al. Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med. 2004;140(11):857\u201366.","journal-title":"Ann Intern Med"},{"issue":"4","key":"367_CR27","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/str.36.4.902","volume":"36","author":"WM Landau","year":"2005","unstructured":"Landau WM, Nassief A. Editorial comment--time to burn the TOAST. Stroke. 2005;36(4):902\u20134.","journal-title":"Stroke"},{"issue":"1","key":"367_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00415-011-6137-3","volume":"259","author":"S Martinez-Ramirez","year":"2012","unstructured":"Martinez-Ramirez S, Delgado-Mederos R, Marin R, Suarez-Calvet M, Sainz MP, Alejaldre A, et al. Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case-control study and a meta-analysis. J Neurol. 2012;259(1):111\u20138.","journal-title":"J Neurol"},{"issue":"5","key":"367_CR29","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1161\/STROKEAHA.108.532473","volume":"40","author":"N Meier","year":"2009","unstructured":"Meier N, Nedeltchev K, Brekenfeld C, Galimanis A, Fischer U, Findling O, et al. Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke. Stroke. 2009;40(5):1729\u201337.","journal-title":"Stroke"},{"issue":"21","key":"367_CR30","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1161\/CIRCULATIONAHA.111.060087","volume":"125","author":"SK Feske","year":"2012","unstructured":"Feske SK. Thrombolytic therapy of acute stroke. Circulation. 2012;125(21):2662\u20136.","journal-title":"Circulation"},{"issue":"7","key":"367_CR31","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.08.008","volume":"22","author":"AD Kumar","year":"2013","unstructured":"Kumar AD, Boehme AK, Siegler JE, Gillette M, Albright KC, Martin-Schild S. Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes. J Stroke Cerebrovasc Dis. 2013;22(7):e111\u20137.","journal-title":"J Stroke Cerebrovasc Dis"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-015-0367-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0367-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0367-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0367-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T18:20:37Z","timestamp":1630606837000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-015-0367-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["367"],"URL":"https:\/\/doi.org\/10.1186\/s12883-015-0367-4","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]},"assertion":[{"value":"2 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"122"}}